GLP-1 Market
LLY $1169.60 ▼ -1.6% NVO $38.18 ▼ -0.2% PFE $27.82 ▼ -0.6% VKTX $27.73 ▼ -2.8% KLRA $10.00 ▼ -5.0% GPCR $25.67 ▼ -3.8% RHHBY $53.29 ▼ -1.4%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Adalimumab

Company
Yale University
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
35 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

35 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026

Find a Clinical Trial Near Me

See recruiting studies for Adalimumab and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01848028

    PsoBest - The German Psoriasis Registry

    Universitätsklinikum Hamburg-Eppendorf 3500 participants Est. completion 2032-12 1 site
    Other conditions: Psoriasis, Psoriatic-arthritis
    View official trial listing →
  • Recruiting NCT NCT03414502

    Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

    Not yet reported University of Nebraska 400 participants Est. completion 2029-03 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT03681652

    Post-Operative Crohn's Disease Outcome in Children

    Schneider Children's Medical Center, Israel 100 participants Est. completion 2027-03-01 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT03827876

    Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

    Not yet reported Psoriasis Treatment Center of Central New Jersey 30 participants Est. completion 2019-12-15 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Recruiting NCT NCT04183608

    A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

    Not yet reported Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 238 participants Est. completion 2028-05 24 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT04300686

    A Pilot Study in Severe Patients With Takayasu Arteritis.

    Not yet reported Shanghai Zhongshan Hospital 40 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Takayasu Arteritis, Tocilizumab, Adalimumab, Treatment
    View official trial listing →
  • Recruiting NCT NCT04372108

    A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

    Janssen Scientific Affairs, LLC 1536 participants Est. completion 2030-08-30 1 site
    Other conditions: Crohn Disease, Colitis, Ulcerative
    View official trial listing →
  • Recruiting NCT NCT05169593

    Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy

    Not yet reported Universitaire Ziekenhuizen KU Leuven 292 participants Est. completion 2030-10 28 sites
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT05305066

    Stand UP to Rheumatoid Arthritis (SUPRA)

    Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT05503875

    Immunoclassification of Psoriasis: a Strategy for Precision Medicine

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Immunoclassification, Psoriasis
    View official trial listing →
  • Recruiting NCT NCT05590455

    Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

    Not yet reported ANRS, Emerging Infectious Diseases 130 participants Est. completion 2027-12 3 sites Stand-alone
    Other conditions: Tuberculous Meningitis, HIV I Infection
    View official trial listing →
  • Recruiting NCT NCT05599347

    Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

    Not yet reported Rambam Health Care Campus 180 participants Est. completion 2027-09-10 9 sites
    Other conditions: Crohn's Disease Relapse, Biological Substance; Adverse Effect
    View official trial listing →
  • Recruiting NCT NCT05781152

    Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    Not yet reported Connecticut Children's Medical Center 900 participants Est. completion 2029-07-01 26 sites
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT05928039

    PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease

    Not yet reported University of Calgary 297 participants Est. completion 2028-12-31 20 sites
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT06037811

    Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

    Not yet reported Tom Appleton 30 participants Est. completion 2028-12 1 site
    Other conditions: Inflammatory Arthritis, Immune-related Adverse Event
    View official trial listing →
  • Recruiting NCT NCT06045754

    A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    Not yet reported Takeda 50 participants Est. completion 2027-06-28 48 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Recruiting NCT NCT06062875

    Effects of TNF Blockade on Human BPH/LUTS

    Not yet reported Endeavor Health 70 participants Est. completion 2028-06-01 1 site
    Other conditions: Benign Prostatic Hyperplasia (BPH)
    View official trial listing →
  • Recruiting NCT NCT06528431

    Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 180 participants Est. completion 2027-12-19 8 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Recruiting NCT NCT06654882

    Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

    Not yet reported Duke University 400 participants Est. completion 2029-11 7 sites
    Other conditions: Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
    View official trial listing →
  • Recruiting NCT NCT06849908

    Baricitinib in the Treatment of Intestinal Behçet's Syndrome

    Not yet reported Peking Union Medical College Hospital 56 participants Est. completion 2028-06-30 2 sites Stand-alone
    Other conditions: Behcet Syndrome, Intestinal Type
    View official trial listing →
  • Recruiting NCT NCT06941376

    Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing Polychondritis

    Not yet reported University of Pennsylvania 20 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Relapsing Polychondritis
    View official trial listing →
  • Recruiting NCT NCT06954311

    Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease

    Medical University Innsbruck 120 participants Est. completion 2030-02-17 10 sites
    Other conditions: Ulcerative Colitis (UC), IBD-unclassified (IBD-U)
    View official trial listing →
  • Recruiting NCT NCT06996652

    An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    Not yet reported Yale University 108 participants Est. completion 2030-01-01 19 sites Stand-alone
    Other conditions: REM Sleep Behavior Disorder
    View official trial listing →
  • Recruiting NCT NCT07021495

    SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

    Leiden University Medical Center 840 participants Est. completion 2029-12-31 8 sites
    Other conditions: Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD), CTCL/ Mycosis Fungoides
    View official trial listing →
  • Recruiting NCT NCT07128472

    Evaluation of IL 12B Genetic Polymorphism (rs3213094)

    Not yet reported South Valley University 40 participants Est. completion 2026-02-01 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Recruiting NCT NCT07138898

    Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

    Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 site Stand-alone
    Other conditions: Rheumatic Disease
    View official trial listing →
  • Recruiting NCT NCT07151937

    A Study of LAD191 in Adults With Hidradenitis Suppurativa

    Not yet reported Almirall, S.A. 200 participants Est. completion 2027-11-25 1 site
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Recruiting NCT NCT07491913

    Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission

    Not yet reported Marmara University 40 participants Est. completion 2027-12-15 1 site Stand-alone
    Other conditions: Takayasu Arteritis
    View official trial listing →
  • Recruiting NCT NCT07510191

    TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 312 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Crohn Disease (CD)
    View official trial listing →
  • Recruiting NCT NCT07522528

    Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

    Not yet reported University of Glasgow 90 participants Est. completion 2030-08 6 sites Stand-alone
    Other conditions: Crohn's Disease (CD)
    View official trial listing →
  • Recruiting NCT NCT07564505

    A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30 participants Est. completion 2029-03 1 site Stand-alone
    Other conditions: Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
    View official trial listing →
  • Recruiting NCT NCT07595770

    Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 37 participants Est. completion 2029-10-01 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma (ESCC)
    View official trial listing →
  • Recruiting NCT NCT07644117

    Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease

    Shmuel Kivity, MD 40 participants Est. completion 2028-12 1 site
    Other conditions: IBD (Inflammatory Bowel Disease), Crohn Disease (CD), Ulcerative Colitis (UC)
    View official trial listing →
  • Recruiting NCT NCT07663526

    Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50 participants Est. completion 2029-03 7 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Recruiting NCT NCT07694674

    Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

    Shanghai 10th People's Hospital 198 participants Est. completion 2026-10-31 1 site
    Other conditions: Inflamatory Bowel Disease, Crohn Disease (CD)
    View official trial listing →
  • Completed NCT NCT00048542

    Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

    Not yet reported Abbott 171 participants Est. completion 2010-06 31 sites Stand-alone
    Other conditions: Arthritis, Juvenile Idiopathic
    View official trial listing →
  • Completed NCT NCT00055497

    Remission in Subjects With Crohn's Disease, 1 Year Phase

    Not yet reported Abbott 276 participants Est. completion 2008-12 43 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00085644

    Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

    Not yet reported Abbott 315 participants Est. completion 2009-07 22 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00105300

    Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

    Not yet reported Abbott 300 participants 56 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00124982

    Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

    Not yet reported Bristol-Myers Squibb 1286 participants Est. completion 2009-08 148 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00133315

    TNFalfa Blocking Treatment of Spondylarthropathies

    Not yet reported Hvidovre University Hospital 50 participants Est. completion 2007-04 9 sites
    Other conditions: Spondylarthropathies, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00185562

    A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis

    Not yet reported Stanford University 12 participants Est. completion 2006-01 1 site
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT00193648

    Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

    Not yet reported Northwell Health 21 participants Est. completion 2007-10 2 sites
    Other conditions: Focal Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00195650

    Long Term Open Label Continuation Study

    Not yet reported Abbott 846 participants Est. completion 2011-05 92 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00195663

    Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

    Not yet reported AbbVie (prior sponsor, Abbott) 799 participants Est. completion 2012-04 123 sites Stand-alone
    Other conditions: Early Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00234234

    Predictors of the Response to Adalimumab in Rheumatoid Arthritis

    Not yet reported University Hospital, Rouen 200 participants Est. completion 2008-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00234897

    Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

    Not yet reported Abbott 1938 participants 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00234936

    Quality of Life Study With Adalimumab in Rheumatoid Arthritis

    Not yet reported Abbott 200 participants
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00235105

    D2E7-Early AS

    Not yet reported, Not yet reported Charite University, Berlin, Germany 46 participants Est. completion 2007-06 2 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00235820

    Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported Abbott 271 participants 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00235859

    Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate

    Not yet reported Abbott 128 participants
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00235872

    Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

    Not yet reported Abbott 309 participants 25 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00235885

    Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

    Not yet reported Abbott 445 participants 1 site
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00237887

    Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported Abbott 1212 participants
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00274352

    A Study of Adalimumab to Treat Sarcoidosis of the Skin

    Not yet reported Pariser, Robert J., M.D. 16 participants Est. completion 2012-02 1 site
    Other conditions: Sarcoidosis
    View official trial listing →
  • Terminated NCT NCT00298272

    Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis

    Not yet reported Biogen 54 participants Est. completion 2011-07 18 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00305539

    HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis

    Not yet reported Assistance Publique - Hôpitaux de Paris 69 participants Est. completion 2011-05 1 site
    Other conditions: Giant Cell Arteritis
    View official trial listing →
  • Terminated NCT NCT00325078

    Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 40 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease, Crohn'S-like IBD, Inflammatory Bowel Disease (IBD)
    View official trial listing →
  • Status unknown NCT NCT00348153

    Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)

    Not yet reported, Not yet reported Heidelberg University 40 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00409617

    Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

    Not yet reported Abbott 945 participants Est. completion 2008-07 189 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00409682

    Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

    Not yet reported Abbott 192 participants Est. completion 2010-05 45 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00421642

    Open-Label Adalimumab for Ulcerative Colitis Patients

    Not yet reported Mayo Clinic 20 participants Est. completion 2008-04 3 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00427362

    A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

    Not yet reported Abbott 127 participants
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00427921

    Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

    Not yet reported Abbott 304 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT00477893

    Danish Multicenter Study of Adalimumab in Spondyloarthritis

    Not yet reported Glostrup University Hospital, Copenhagen 52 participants Est. completion 2013-01 13 sites
    Other conditions: Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT00478660

    An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

    Not yet reported Abbott 1250 participants 205 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00497614

    Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

    Not yet reported University Hospital, Tours 8 participants Est. completion 2008-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT00512863

    A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

    Not yet reported Abbott 272 participants
    Other conditions: Asthma
    View official trial listing →
  • Withdrawn NCT NCT00514982

    Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2011-03-08 1 site
    Other conditions: Hermanski-Pudlak Syndrome, Colitis, Cytokines, Lymphocytes, Drug Evaluation
    View official trial listing →
  • Completed NCT NCT00517296

    Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas

    Not yet reported Vanderbilt University Medical Center 21 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Crohn Disease, Rectal Fistula
    View official trial listing →
  • Completed NCT NCT00525902

    Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis

    Not yet reported Oregon Health and Science University 31 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00538902

    Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

    Not yet reported, Not yet reported Abbott 302 participants Est. completion 2009-12 11 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00550446

    A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

    Not yet reported Pfizer 386 participants Est. completion 2009-01 63 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00573794

    Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

    Not yet reported AbbVie (prior sponsor, Abbott) 592 participants Est. completion 2016-12 Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00574249

    Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

    Not yet reported Abbott 730 participants 131 sites
    Other conditions: Chronic Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00595413

    Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

    Not yet reported EMD Serono 311 participants Est. completion 2009-10 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00597623

    Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis

    Not yet reported Assistance Publique - Hôpitaux de Paris 84 participants Est. completion 2010-12 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT00638261

    Primary UVB-311nm and Adalimumab in Psoriasis Patients

    Not yet reported Medical University of Graz 4 participants Est. completion 2011-08 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT00638469

    UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis

    Not yet reported Medical University of Graz 10 participants Est. completion 2014-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00645905

    Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported Abbott 148 participants
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00646178

    Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

    Not yet reported Abbott 102 participants
    Other conditions: Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT00646386

    Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

    Not yet reported Abbott 315 participants
    Other conditions: Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT00647270

    Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

    Not yet reported Abbott 420 participants Est. completion 2009-04 86 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00647400

    Adalimumab in Adult Japanese Subjects With Psoriasis

    Not yet reported, Not yet reported Abbott 147 participants Est. completion 2010-04 64 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00647491

    A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

    Not yet reported, Not yet reported Abbott 352 participants Est. completion 2005-08 25 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Approved For Marketing NCT NCT00649545

    Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

    Abbott
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Approved For Marketing NCT NCT00650026

    Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis

    Abbott
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00650156

    Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

    Not yet reported AbbVie 24 participants 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00667355

    A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

    Not yet reported Abbott 41 participants Est. completion 2011-01 19 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00686374

    Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

    Not yet reported AbbVie (prior sponsor, Abbott) 100 participants Est. completion 2017-04-04 Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00686439

    Adalimumab for Inflammatory Osteoarthritis

    Not yet reported, Not yet reported University of Alberta 20 participants Est. completion 2010-11 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Withdrawn NCT NCT00690846

    Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

    Not yet reported Wake Forest University Health Sciences Est. completion 2007-07 1 site Stand-alone
    Other conditions: Pyoderma Gangrenosum
    View official trial listing →
  • Withdrawn NCT NCT00690911

    Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis

    Not yet reported Wake Forest University 1 site Stand-alone
    Other conditions: Sarcoidosis
    View official trial listing →
  • Completed NCT NCT00696059

    Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?

    Not yet reported Hvidovre University Hospital 52 participants Est. completion 2007-07 5 sites
    Other conditions: Rheumatoid Arthritis, Arthritis, Joint Diseases
    View official trial listing →
  • Completed NCT NCT00714493

    RESTART C0168Z05 Rheumatoid Arthritis Study

    Not yet reported Centocor Ortho Biotech Services, L.L.C. 203 participants Est. completion 2010-06 76 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT00731757

    Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

    Not yet reported Wright State University Est. completion 2010-12 1 site
    Other conditions: Sarcoidosis, Cutaneous Sarcoidosis
    View official trial listing →
  • Status unknown NCT NCT00745329

    The Effect of Infliximab on Sperm Quality

    Tel-Aviv Sourasky Medical Center 100 participants
    Other conditions: Crohn's Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00775437

    Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use

    Not yet reported AbbVie (prior sponsor, Abbott) 32 participants Est. completion 2013-03 Stand-alone
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT00780793

    Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study

    Not yet reported Assistance Publique - Hôpitaux de Paris 250 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00796705

    Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2010-10 16 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00808210

    A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab

    Not yet reported Genentech, Inc. 28 participants Est. completion 2012-11-14 53 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00808509

    A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission

    Not yet reported AbbVie (prior sponsor, Abbott) 33 participants Est. completion 2012-09 8 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00814255

    Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

    Not yet reported NYU Langone Health 32 participants Est. completion 2014-02 18 sites Stand-alone
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00837434

    Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 63 participants Est. completion 2014-01 7 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00851565

    Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

    Not yet reported Copenhagen University Hospital at Herlev 120 participants Est. completion 2014-02 8 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00853099

    A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

    Not yet reported AbbVie (prior sponsor, Abbott) 274 participants Est. completion 2013-08 65 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00853385

    A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

    Not yet reported Pfizer 717 participants Est. completion 2011-03 125 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00855608

    Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study

    Not yet reported Rafic Hariri University Hospital 15 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Uveitis, Diabetic Retinopathy, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT00870467

    A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis

    Not yet reported Abbott 334 participants Est. completion 2011-08 88 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00918255

    Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa

    Not yet reported Abbott 154 participants Est. completion 2010-11 26 sites Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT00927069

    Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

    Not yet reported Innovaderm Research Inc. 85 participants Est. completion 2008-12 12 sites Stand-alone
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00929864

    Abatacept Versus Adalimumab Head-to-Head

    Not yet reported Bristol-Myers Squibb 869 participants Est. completion 2012-11 83 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00932113

    Mechanism of Action Study for Psoriasis

    Not yet reported Tufts Medical Center 33 participants Est. completion 2017-05-01 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00939003

    Study of Adalimumab in Patients With Axial Spondyloarthritis

    Not yet reported AbbVie (prior sponsor, Abbott) 192 participants Est. completion 2013-08 38 sites Stand-alone
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT00940862

    Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

    Not yet reported Innovaderm Research Inc. 30 participants Est. completion 2011-08 2 sites Stand-alone
    Other conditions: Psoriasis, Vascular Inflammation, Coronary Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00963313

    A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis

    Dr. FRANCISCO J. BLANCO-GARCIA 29 participants Est. completion 2014-06 22 sites
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01004432

    Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

    Not yet reported Janssen Biotech, Inc. 433 participants Est. completion 2013-10 117 sites
    Other conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases
    View official trial listing →
  • Terminated NCT NCT01012570

    The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

    Gerhard Rogler 34 participants 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01021735

    Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

    Not yet reported University of Glasgow 302 participants Est. completion 2015-04 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01029613

    Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers

    Glostrup University Hospital, Copenhagen 40 participants Est. completion 2013-07 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01064856

    Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

    Not yet reported AbbVie (prior sponsor, Abbott) 165 participants Est. completion 2014-05 Stand-alone
    Other conditions: Peripheral Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT01076205

    Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis

    AbbVie (prior sponsor, Abbott) 7229 participants Est. completion 2017-09-14
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01076959

    Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis

    Abbott 7972 participants Est. completion 2011-06 1723 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01077258

    Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

    AbbVie (prior sponsor, Abbott) 4208 participants Est. completion 2013-02 303 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01078116

    Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)

    Abbott 124 participants Est. completion 2010-06 10 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01078155

    Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis

    AbbVie (prior sponsor, Abbott) 131 participants Est. completion 2014-05
    Other conditions: Rheumatoid Arthritis, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01078402

    EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries

    AbbVie (prior sponsor, Abbott) 809 participants Est. completion 2011-11 163 sites
    Other conditions: Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA, Rheumatoid Arthritis (RA
    View official trial listing →
  • Completed NCT NCT01078558

    A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

    AbbVie (prior sponsor, Abbott) 5940 participants Est. completion 2018-01-11
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis
    View official trial listing →
  • Withdrawn NCT NCT01078610

    Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

    Abbott
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01079182

    Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

    AbbVie (prior sponsor, Abbott) 4681 participants Est. completion 2014-05
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT01083160

    Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use

    Abbott 82 participants Est. completion 2010-11 12 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01083680

    Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine

    AbbVie (prior sponsor, Abbott) 4107 participants Est. completion 2015-12
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01083693

    Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs

    Abbott 162 participants Est. completion 2010-06 20 sites
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01084668

    Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs

    Abbott 46 participants Est. completion 2011-04 9 sites
    Other conditions: Psoriasis Chronic
    View official trial listing →
  • Completed NCT NCT01086033

    A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

    AbbVie (prior sponsor, Abbott) 566 participants Est. completion 2012-07 60 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01088165

    The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis

    Not yet reported Medical University of Vienna 66 participants Est. completion 2014-05 1 site Stand-alone
    Cardiovascular diseaseType 2 diabetes Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01105741

    Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD)

    Martin Storr 25 participants Est. completion 2013-12 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01111240

    Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice

    AbbVie (prior sponsor, Abbott) 4635 participants Est. completion 2013-12 509 sites
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01114880

    Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

    Not yet reported Abbott 344 participants Est. completion 2011-02 9 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT01119859

    A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

    Not yet reported Hoffmann-La Roche 326 participants Est. completion 2012-01 82 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01124838

    Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis

    Not yet reported AbbVie (prior sponsor, Abbott) 261 participants Est. completion 2015-05 Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT01136252

    Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 5 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Age-Related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT01137838

    Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents

    Bristol-Myers Squibb 1810 participants Est. completion 2010-10
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01138657

    Efficacy and Safety of Adalimumab in Patients With Active Uveitis

    Not yet reported AbbVie (prior sponsor, Abbott) 239 participants Est. completion 2014-08 Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Status unknown NCT NCT01144156

    Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy

    Not yet reported Rabin Medical Center 30 participants 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01148225

    A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis

    Not yet reported AbbVie 424 participants Est. completion 2018-05-21
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT01155570

    Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)

    AbbVie (prior sponsor, Abbott) 752 participants Est. completion 2012-07 634 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT01156532

    Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

    AbbVie (prior sponsor, Abbott) 30 participants Est. completion 2013-08 3 sites
    Other conditions: Moderate to Severe Psoriasis
    View official trial listing →
  • Completed NCT NCT01162421

    A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

    Not yet reported AbbVie (prior sponsor, Abbott) 77 participants Est. completion 2015-07 Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01163292

    Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))

    AbbVie (prior sponsor, Abbott) 220 participants Est. completion 2012-10 75 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01163617

    The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

    Not yet reported AbbVie (prior sponsor, Abbott) 85 participants Est. completion 2010-11 10 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01163916

    Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

    Abbott 252 participants Est. completion 2011-11 43 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT01166282

    A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis

    Not yet reported AbbVie (prior sponsor, Abbott) 46 participants Est. completion 2015-12 Stand-alone
    Other conditions: Enthesitis Related Arthritis (ERA)
    View official trial listing →
  • Completed NCT NCT01166620

    Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics

    Bristol-Myers Squibb 4000 participants Est. completion 2012-03
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01169987

    Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life

    AbbVie (prior sponsor, Abbott) 191 participants Est. completion 2015-03
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01174186

    Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing

    Not yet reported Regionshospitalet Silkeborg 30 participants Est. completion 2014-03 4 sites
    Other conditions: Spondyloarthritis, Enterocolitis
    View official trial listing →
  • Completed NCT NCT01181570

    Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

    Not yet reported Innovaderm Research Inc. 20 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Psoriasis, Sleep Apnea, Obstructive
    View official trial listing →
  • Completed NCT NCT01185301

    Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)

    Not yet reported AbbVie (prior sponsor, Abbott) 395 participants Est. completion 2012-09 68 sites
    Other conditions: Early Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01219257

    Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy

    Diakonhjemmet Hospital 50 participants Est. completion 2016-01 1 site
    Other conditions: Spondyloarthritis, Ultrasonography
    View official trial listing →
  • Completed NCT NCT01225393

    A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

    Not yet reported Genentech, Inc. 211 participants 67 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01231321

    A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

    Not yet reported Abbott 100 participants Est. completion 2010-02 5 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01233583

    Regulatory T-cells in Psoriasis Patients as Targets for Therapy

    University of Aberdeen 38 participants Est. completion 2013-09 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01235689

    Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

    Not yet reported AbbVie (prior sponsor, Abbott) 252 participants Est. completion 2017-01-03 Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01243671

    A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease

    Not yet reported AbbVie (prior sponsor, Abbott) 20 participants Est. completion 2013-06 12 sites Stand-alone
    Other conditions: Intestinal Behçet's Disease
    View official trial listing →
  • Terminated NCT NCT01264770

    Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)

    Not yet reported AstraZeneca 644 participants Est. completion 2013-08 105 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01275508

    Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut

    Not yet reported, Not yet reported University of Erlangen-Nürnberg Medical School 25 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01282372

    Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

    AbbVie (prior sponsor, Abbott) 500 participants Est. completion 2014-07
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Terminated NCT NCT01283971

    A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

    Not yet reported Hoffmann-La Roche 96 participants Est. completion 2012-08 170 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01295151

    SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.

    Not yet reported Julia Brown 122 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01295814

    Efficacy Study of Adalimumab to Treat Interstitial Cystitis

    Not yet reported ICStudy, LLC 43 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Interstitial Cystitis
    View official trial listing →
  • Completed NCT NCT01316224

    Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment

    AbbVie (prior sponsor, Abbott) 52 participants Est. completion 2014-04 15 sites
    Other conditions: Psoriasis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01320293

    Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

    Not yet reported University of North Carolina, Chapel Hill 18 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01328366

    Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab

    AbbVie (prior sponsor, Abbott) 153 participants Est. completion 2014-05
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01329380

    Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

    AbbVie 403 participants Est. completion 2017-12-28 194 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT01346501

    Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069

    AbbVie (prior sponsor, Abbott) 172 participants Est. completion 2014-11
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01356758

    Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents

    University of Aarhus 126 participants Est. completion 2015-11 1 site
    Other conditions: Psoriasis, Atopic Dermatitis, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01373151

    Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

    Not yet reported CSL Behring 418 participants Est. completion 2015-06 100 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01382160

    Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)

    Not yet reported University Hospital, Tours 69 participants Est. completion 2013-07 7 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01383421

    Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)

    AbbVie (prior sponsor, Abbott) 1036 participants Est. completion 2016-04
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01387789

    A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

    AbbVie (prior sponsor, Abbott) 71 participants Est. completion 2013-03 13 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01387802

    Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

    AbbVie (prior sponsor, Abbott) 722 participants Est. completion 2019-12-16 56 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT01401452

    Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

    AbbVie (prior sponsor, Abbott) 246 participants Est. completion 2016-05
    Other conditions: Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT01405326

    REstore Working Ability in RheumatoiD Arthritis

    Not yet reported The Rheumatological Center of Helsinki 160 participants Est. completion 2013-03 4 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01412021

    Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis

    AbbVie 375 participants Est. completion 2018-04-02
    Other conditions: Arthritis, Juvenile Rheumatoid
    View official trial listing →
  • Completed NCT NCT01428115

    Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab

    AbbVie (prior sponsor, Abbott) 83 participants Est. completion 2013-10 8 sites
    Other conditions: Severe Crohn's Disease, Anxiety
    View official trial listing →
  • Completed NCT NCT01435265

    Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab

    Not yet reported Wake Forest University Health Sciences 7 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT01464021

    A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

    AbbVie (prior sponsor, Abbott) 26 participants Est. completion 2012-12 3 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT01464333

    Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

    AbbVie (prior sponsor, Abbott) 511 participants Est. completion 2018-03-31
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01468207

    Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa

    Not yet reported AbbVie (prior sponsor, Abbott) 307 participants Est. completion 2014-01 Stand-alone
    Other conditions: Hidradenitis Suppurativa (HS)
    View official trial listing →
  • Completed NCT NCT01468233

    Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa

    Not yet reported AbbVie (prior sponsor, Abbott) 326 participants Est. completion 2014-04 Stand-alone
    Other conditions: Hidradenitis Suppurativa (HS)
    View official trial listing →
  • Completed NCT NCT01474876

    Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

    AbbVie (prior sponsor, Abbott) 566 participants Est. completion 2014-05
    Other conditions: Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01483599

    A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis

    Not yet reported Janssen Inc. 293 participants Est. completion 2013-08-05 40 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT01494857

    Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

    Not yet reported Clalit Health Services 200 participants Est. completion 2013-12 3 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01500278

    Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

    Not yet reported UCB Pharma SA 915 participants Est. completion 2016-01 175 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01502423

    A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

    Not yet reported AbbVie (prior sponsor, Abbott) 61 participants Est. completion 2012-11 7 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01505491

    Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects

    Not yet reported Boehringer Ingelheim 193 participants Est. completion 2012-07-01 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01505855

    Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

    Not yet reported Kyunghee University Medical Center 197 participants Est. completion 2013-06 15 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT01543204

    Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

    Not yet reported Amgen 64 participants Est. completion 2015-05-29 47 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01553058

    Vascular Inflammation in Psoriasis Trial (The VIP Trial)

    Not yet reported University of Pennsylvania 97 participants Est. completion 2016-10-27 9 sites
    Cardiovascular disease Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT01562951

    Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

    Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 15 participants Est. completion 2014-03 30 sites
    Obstructive sleep apnea Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01564823

    Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease

    Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 86 participants Est. completion 2015-01 22 sites
    Other conditions: Crohn´s Disease
    View official trial listing →
  • Completed NCT NCT01585064

    Optimization of Treatment With Adalimumab (Humira)

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 309 participants Est. completion 2010-02 1 site
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT01592292

    An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy

    Hoffmann-La Roche 90 participants Est. completion 2014-12 15 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01602302

    Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis

    Not yet reported Medical University of Graz 40 participants Est. completion 2020-11-19 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01609205

    Doppler Evaluation in RA Patients After Adalimumab.

    Not yet reported Hamed Rezaei 60 participants Est. completion 2017-09 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01610947

    Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity

    Not yet reported University Hospital, Montpellier 398 participants Est. completion 2018-10-18 1 site
    Other conditions: Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT01613963

    Causes of Visual Loss in Retinal Disease

    Royal Surrey County Hospital NHS Foundation Trust 2000 participants Est. completion 2012-12 2 sites
    Other conditions: Uveitis, Scleritis
    View official trial listing →
  • Completed NCT NCT01635764

    Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa

    Not yet reported AbbVie (prior sponsor, Abbott) 508 participants Est. completion 2016-08 Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT01644396

    An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation

    Not yet reported AbbVie (prior sponsor, Abbott) 50 participants Est. completion 2013-09 7 sites
    Other conditions: Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT01657513

    TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

    Not yet reported University Hospital, Gentofte, Copenhagen 60 participants 2 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01670240

    Adalimumab in the Treatment of Chronic Pouchitis

    Not yet reported Odense University Hospital 13 participants Est. completion 2016-01 1 site
    Other conditions: Ulcerative Colitis, Pouchitis
    View official trial listing →
  • Withdrawn NCT NCT01674413

    Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)

    Not yet reported Peter Higgins Est. completion 2016-03 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01695239

    A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

    Not yet reported Eli Lilly and Company 417 participants Est. completion 2017-09 116 sites
    Other conditions: Psoriasis, Arthritic
    View official trial listing →
  • Completed NCT NCT01698307

    Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy

    Not yet reported Alimentiv Inc. 1095 participants Est. completion 2020-04-16 22 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT01716039

    Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

    Not yet reported Alimentiv Inc. 22 participants Est. completion 2016-07-18
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT01724268

    Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient

    Not yet reported Hamad Medical Corporation 80 participants Est. completion 2014-09 1 site
    Other conditions: RHEUMATOID ARTHRITIS
    View official trial listing →
  • Completed NCT NCT01736189

    Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

    AbbVie (prior sponsor, Abbott) 346 participants Est. completion 2018-04-16
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01752855

    Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

    Not yet reported AbbVie (prior sponsor, Abbott) 88 participants Est. completion 2013-10 20 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01754727

    Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

    AbbVie (prior sponsor, Abbott) 452 participants Est. completion 2015-10
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT01756235

    Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice

    AbbVie (prior sponsor, Abbott) 462 participants Est. completion 2015-10
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01759264

    An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

    AbbVie (prior sponsor, Abbott) 101 participants Est. completion 2014-05
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT01764997

    An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate

    Not yet reported Sanofi 776 participants Est. completion 2015-01 257 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01768858

    Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice

    AbbVie 96 participants Est. completion 2017-08-13
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Crohn´s Disease, Ulcerative Colitis, Plaque Psoriasis
    View official trial listing →
  • Terminated NCT NCT01783015

    Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

    Not yet reported Pfizer 16 participants Est. completion 2014-08 15 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01783730

    Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

    AbbVie 163 participants Est. completion 2015-09
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01793519

    Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis

    Not yet reported Georgetown University 290 participants Est. completion 2024-08-30 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01808118

    Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis

    Not yet reported AbbVie 673 participants Est. completion 2017-04-14 Stand-alone
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT01845818

    Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium

    AbbVie 183 participants Est. completion 2017-06-23
    Other conditions: Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01860963

    Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

    Not yet reported Stanford University 310 participants Est. completion 2013-06 1 site
    Other conditions: Anal Squamous Intraepithelial Lesion (ASIL), HPV DNA
    View official trial listing →
  • Withdrawn NCT NCT01870284

    Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)

    Not yet reported Eli Lilly and Company Est. completion 2018-04 125 sites
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT01870986

    Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)

    Not yet reported Pfizer 210 participants Est. completion 2014-02 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01872546

    Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy

    Not yet reported Poitiers University Hospital 18 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Chronic Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01877668

    Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

    Not yet reported Pfizer 422 participants Est. completion 2015-12-18 123 sites
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01893996

    Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease

    Not yet reported Jonathan Graf 63 participants Est. completion 2017-07 1 site Stand-alone
    Cardiovascular disease Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01895764

    Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)

    Not yet reported University Hospital, Tours 110 participants Est. completion 2015-04-27 11 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT01899755

    A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

    Not yet reported GlaxoSmithKline 45 participants Est. completion 2014-04-03 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT01901627

    A Multicenter Registry of Adalimumab in Chinese Adult Patients With Active Ankylosing Spondylitis

    Peking Union Medical College Hospital 400 participants Est. completion 2015-06 1 site
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Terminated NCT NCT01927757

    Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

    Not yet reported Amgen 90 participants Est. completion 2015-06-11 45 sites
    Other conditions: Moderate to Severe Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01947816

    Special Investigation in Patients With Ulcerative Colitis

    AbbVie 1621 participants Est. completion 2018-02-15
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01954381

    Impact of Adalimumab Therapy on Brachial Endothelial Function and Large Artery Stiffness in Patients With Rheumatoid Arthritis

    Not yet reported Assistance Publique Hopitaux De Marseille 60 participants Est. completion 2015-07 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01958827

    A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease

    Not yet reported AbbVie 28 participants Est. completion 2015-10 Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01960790

    Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)

    AbbVie 473 participants Est. completion 2017-05-15
    Other conditions: Behcet's Disease
    View official trial listing →
  • Completed NCT NCT01970475

    Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis

    Not yet reported Amgen 526 participants Est. completion 2014-11 11 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT01970488

    Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

    Not yet reported Amgen 350 participants Est. completion 2015-03-18 3 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01981473

    Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

    Pfizer 605 participants Est. completion 2014-12 54 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01986127

    Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients

    Not yet reported Sara Varea 26 participants Est. completion 2018-06-30 13 sites Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02019472

    A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis

    Not yet reported Janssen Research & Development, LLC 559 participants Est. completion 2016-08-17 107 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT02065622

    Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

    Not yet reported AbbVie 952 participants Est. completion 2019-11-11 173 sites Stand-alone
    Other conditions: Ulcerative Colitis (UC)
    View official trial listing →
  • Status unknown NCT NCT02075697

    Spanish Registry of Systemic Treatments in Psoriasis

    Fundación Academia Española de Dermatología 3500 participants Est. completion 2025-10 13 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT02092389

    Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

    AbbVie 10 participants Est. completion 2016-03
    Other conditions: Moderate to Severe Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02092467

    Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

    Not yet reported Pfizer 4372 participants Est. completion 2020-07-22 345 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Terminated NCT NCT02092961

    Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study

    Not yet reported AstraZeneca 198 participants Est. completion 2013-07 21 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT02097264

    A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

    Not yet reported Novo Nordisk A/S Est. completion 2015-09 Stand-alone
    Other conditions: Inflammation, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02113904

    Clinical Trial Using Humira in Netherton Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 11 participants Est. completion 2017-09-21 1 site Stand-alone
    Other conditions: Netherton Syndrome
    View official trial listing →
  • Completed NCT NCT02114931

    Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

    Not yet reported Amgen 467 participants Est. completion 2016-04 77 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Status unknown NCT NCT02116504

    Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 156 participants Est. completion 2017-11 1 site
    Other conditions: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT02122406

    Depression and Anxiety in Rheumatoid Arthritis

    University of Pavia 200 participants Est. completion 2015-12 1 site
    Other conditions: Rheumatoid Arthritis, Depression, Anxiety
    View official trial listing →
  • Status unknown NCT NCT02132234

    Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

    Not yet reported Jagiellonian University 100 participants 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Hypertension
    View official trial listing →
  • Status unknown NCT NCT02134054

    Stavanger IBD Study - Cross Sectional

    Helse Stavanger HF 210 participants Est. completion 2024-12 1 site
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT02137226

    BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

    Not yet reported Boehringer Ingelheim 645 participants Est. completion 2016-10-18 138 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT02141997

    A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

    Not yet reported AbbVie 222 participants Est. completion 2015-11
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02144714

    Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects

    Not yet reported Samsung Bioepis Co., Ltd. 189 participants Est. completion 2014-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02150473

    The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients

    Not yet reported Heinrich-Heine University, Duesseldorf 21 participants Est. completion 2017-09-14 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02163759

    A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

    Not yet reported Hoffmann-La Roche 358 participants Est. completion 2020-03-19 88 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02167139

    A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

    Not yet reported Samsung Bioepis Co., Ltd. 544 participants Est. completion 2015-10 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02171429

    A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

    Not yet reported Hoffmann-La Roche 358 participants Est. completion 2020-05-25 90 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02185014

    Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115

    Not yet reported AbbVie 252 participants Est. completion 2017-11-03
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02187055

    An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

    Not yet reported Pfizer 1152 participants Est. completion 2016-12 215 sites Stand-alone
    Other conditions: Rhematoid Arthritis
    View official trial listing →
  • Completed NCT NCT02196701

    Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study

    Not yet reported AbbVie 46 participants Est. completion 2017-03-17 Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02198651

    A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

    Not yet reported AbbVie 149 participants Est. completion 2018-08-08 70 sites Stand-alone
    Other conditions: Rheumatoid Arthritis, Musculoskeletal and Connective Tissue Diseases
    View official trial listing →
  • Completed NCT NCT02206867

    Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

    Not yet reported LG Life Sciences 116 participants Est. completion 2015-02
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02207231

    A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

    Not yet reported Janssen Research & Development, LLC 837 participants Est. completion 2020-06-17 97 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02237729

    A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))

    Not yet reported Pfizer 362 participants Est. completion 2015-03 8 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT02242474

    Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis

    Not yet reported CHU de Quebec-Universite Laval 660 participants Est. completion 2019-10 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02252809

    Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

    Not yet reported Brugmann University Hospital 51 participants Est. completion 2009-07
    Other conditions: Innate Immunity
    View official trial listing →
  • Withdrawn NCT NCT02322723

    Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

    AbbVie Est. completion 2020-02
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02330380

    Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

    University Hospitals Cleveland Medical Center 26 participants Est. completion 2016-12 1 site
    Other conditions: Psoriasis, Inflammation
    View official trial listing →
  • Status unknown NCT NCT02332356

    Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

    Not yet reported Tokyo Medical and Dental University 100 participants Est. completion 2024-03 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT02332590

    Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)

    Not yet reported Sanofi 369 participants Est. completion 2020-12-29 86 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02333383

    Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients

    AbbVie 201 participants Est. completion 2017-08-08
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT02353780

    Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept

    Not yet reported Dr. Larry W. Moreland 10 participants Est. completion 2018-11-30 1 site
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT02362074

    Progress at Work - The Impact of Adalimumab on Work Related Productivity in Patients With Rheumatoid Arthritis

    AbbVie 401 participants Est. completion 2020-03-06 32 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02374021

    Treatments Against RA and Effect on FDG-PET/CT

    Not yet reported Brigham and Women's Hospital 159 participants Est. completion 2021-05 31 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT02376478

    On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

    Medical University of Vienna 222 participants Est. completion 2011-01
    Other conditions: Psoriasis, Inflammatory Bowel Diseases
    View official trial listing →
  • Terminated NCT NCT02393378

    Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

    Not yet reported Takeda 7 participants Est. completion 2016-11-16 13 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02405780

    A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients

    Not yet reported Fujifilm Kyowa Kirin Biologics Co., Ltd. 645 participants Est. completion 2018-01-18 92 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Terminated NCT NCT02413047

    Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator

    Not yet reported Indiana University 3 participants Est. completion 2018-02 1 site
    Other conditions: Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02450513

    Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

    Universitaire Ziekenhuizen KU Leuven 30 participants Est. completion 2016-05-25 2 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02451839

    An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

    AbbVie 168 participants Est. completion 2017-12-05
    Other conditions: Crohn's Disease, Rheumatoid Arthritis, Psoriasis
    View official trial listing →
  • Completed NCT NCT02471118

    Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)

    Not yet reported CARE ARTHRITIS LTD. 62 participants Est. completion 2021-03 7 sites Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02472912

    Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

    Not yet reported Mylan Inc. 270 participants Est. completion 2015-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02480153

    A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

    Not yet reported Pfizer 597 participants Est. completion 2017-12-06 183 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02489227

    Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

    Not yet reported Coherus Oncology, Inc. 545 participants Est. completion 2017-03 99 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02492217

    Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

    Not yet reported Universidade Nova de Lisboa 69 participants Est. completion 2018-05-28 1 site Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT02497469

    An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

    Not yet reported Takeda 771 participants Est. completion 2019-01-18 330 sites Stand-alone
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Completed NCT NCT02499263

    A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice

    AbbVie 150 participants Est. completion 2018-09-17 19 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02499783

    Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

    Not yet reported AbbVie 205 participants Est. completion 2017-12-15 Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02506179

    Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

    AbbVie 100 participants Est. completion 2020-02-10 23 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Withdrawn NCT NCT02516774

    A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris Est. completion 2015-12 1 site Stand-alone
    Other conditions: Anaplastic Thyroid Cancers
    View official trial listing →
  • Status unknown NCT NCT02528292

    Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis

    Barts & The London NHS Trust 24 participants Est. completion 2018-04 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02533375

    Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

    Not yet reported AbbVie 10 participants Est. completion 2017-07-20 Stand-alone
    Other conditions: Generalized Pustular Psoriasis (GPP), Adalimumab, Japanese
    View official trial listing →
  • Completed NCT NCT02572245

    A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects

    Not yet reported Pfizer 164 participants Est. completion 2016-05 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02602925

    Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

    Not yet reported Radboud University Medical Center 120 participants Est. completion 2018-07-20 6 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02619552

    Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

    University of Maryland, Baltimore 50 participants Est. completion 2019-07-01 4 sites
    Other conditions: Crohn's Disease, IBD
    View official trial listing →
  • Completed NCT NCT02620189

    Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

    Queen Mary University of London 60 participants Est. completion 2017-05-24 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT02629159

    A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

    Not yet reported AbbVie 1629 participants Est. completion 2027-09-30 370 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02632175

    Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis

    Not yet reported AbbVie 59 participants Est. completion 2025-04-08 16 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT02634541

    Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis

    Not yet reported University of Helsinki 60 participants Est. completion 2017-12 2 sites Stand-alone
    Other conditions: Ankylosing Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT02640612

    Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

    Not yet reported Boehringer Ingelheim 430 participants Est. completion 2017-11-01 91 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT02660580

    MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported Fresenius Kabi SwissBioSim GmbH 443 participants Est. completion 2017-12-18 76 sites
    Other conditions: Psoriasis, Plaque Type Psoriasis, Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02674308

    Entyvio (Vedolizumab) Long Term Safety Study

    Takeda 5302 participants Est. completion 2021-07-30 287 sites
    Other conditions: Ulcerative Colitis and Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02713295

    A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece

    AbbVie 273 participants Est. completion 2019-04-19 43 sites
    Other conditions: Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02714322

    MYL-1401A Efficacy and Safety Comparability Study to Humira®

    Not yet reported Mylan Inc. 294 participants Est. completion 2017-03 33 sites Stand-alone
    Other conditions: Psoriasis, Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT02738125

    Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

    AbbVie 265 participants Est. completion 2023-12-15 80 sites
    Other conditions: Ulcerative Colitis (UC)
    View official trial listing →
  • Completed NCT NCT02745080

    Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis

    Not yet reported Novartis Pharmaceuticals 853 participants Est. completion 2019-12-30 156 sites
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT02750800

    Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)

    AbbVie 427 participants Est. completion 2018-04-03
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Psoriasis, Crohn's Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02760407

    Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

    Not yet reported R-Pharm International, LLC 1648 participants Est. completion 2019-11-05 203 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02764762

    Triple Combination Therapy in High Risk Crohn's Disease (CD)

    Not yet reported Takeda 55 participants Est. completion 2022-07-05 32 sites Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT02778789

    Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers

    University of Erlangen-Nürnberg Medical School 66 participants Est. completion 2018-03-31 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT02779114

    RETRO (REduction of Therapy in RA Patients in Ongoing Remission)

    Not yet reported University of Erlangen-Nürnberg Medical School 318 participants Est. completion 2018-06 12 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT02786563

    Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate

    AbbVie Est. completion 2018-11-21 4 sites
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT02786576

    Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting

    AbbVie 236 participants Est. completion 2019-01-07 83 sites
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Terminated NCT NCT02829424

    Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

    Not yet reported Assistance Publique Hopitaux De Marseille 78 participants Est. completion 2024-02-10 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02833350

    Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)

    Not yet reported Genentech, Inc. 578 participants Est. completion 2018-07-02 150 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02840175

    Treatment Tapering in JIA With Inactive Disease

    Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2020-10-01 1 site Stand-alone
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Status unknown NCT NCT02852850

    In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis

    Shandong University 30 participants 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02871635

    BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

    Not yet reported Boehringer Ingelheim 147 participants Est. completion 2019-05-13 92 sites
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT02889796

    Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

    Not yet reported Gilead Sciences 1759 participants Est. completion 2019-06-20 230 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02896985

    Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA )

    AbbVie 98 participants Est. completion 2020-03-11 24 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT02897115

    A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment

    Not yet reported AbbVie 22 participants Est. completion 2017-12-21 Stand-alone
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT02927353

    A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects

    Not yet reported Meiji Seika Pharma Co., Ltd. 180 participants Est. completion 2017-01-17 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02929251

    Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis

    Not yet reported Assistance Publique - Hôpitaux de Paris 112 participants Est. completion 2022-01-29 27 sites
    Other conditions: Uveitis, Biotherapy
    View official trial listing →
  • Completed NCT NCT02994836

    GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )

    Not yet reported Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 139 participants Est. completion 2022-12-31 1 site
    Other conditions: Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03001115

    Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

    AbbVie 17 participants Est. completion 2019-07-31 19 sites
    Other conditions: Hidradenitis Suppurativa (HS)
    View official trial listing →
  • Terminated NCT NCT03017014

    A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions

    AbbVie 62 participants Est. completion 2019-10-14 24 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT03100253

    Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation

    Not yet reported Mario Negri Institute for Pharmacological Research 208 participants Est. completion 2021-12-31 22 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT03104400

    A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)

    Not yet reported AbbVie 1705 participants Est. completion 2024-09-09 345 sites Stand-alone
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT03110094

    Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis

    Not yet reported Rennes University Hospital 59 participants Est. completion 2020-01-13 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT03142113

    Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis

    Universitaire Ziekenhuizen KU Leuven 231 participants Est. completion 2017-05 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT03153319

    Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI

    Not yet reported, Not yet reported Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 14 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI
    View official trial listing →
  • Completed NCT NCT03172325

    Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA

    Not yet reported Cinnagen 136 participants Est. completion 2017-01-04 10 sites Stand-alone
    Other conditions: Active Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT03172377

    Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients

    Not yet reported Radboud University Medical Center 174 participants Est. completion 2022-10 22 sites Stand-alone
    Other conditions: Crohn Disease in Remission, Crohn Disease
    View official trial listing →
  • Completed NCT NCT03210259

    The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis

    Not yet reported Boehringer Ingelheim 259 participants Est. completion 2019-04-16 49 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT03217734

    MAP Study: Methotrexate and Adalimumab in Psoriasis

    Not yet reported, Not yet reported Jeffrey J Crowley MD 56 participants Est. completion 2018-12-31 4 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT03223012

    Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

    AbbVie 116 participants Est. completion 2019-02-28 15 sites
    Other conditions: Crohn's Disease, Ulcerative Colitis (UC), Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, Ankylosing Spondylitis (AS), Non-radiographic Axial Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT03248531

    A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.

    Not yet reported UCB Biopharma SRL 90 participants Est. completion 2019-02-21 31 sites
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT03254810

    Comparison of the Safety and PK of SYN060 to Humira® in Healthy Adult Subjects

    Not yet reported Synermore Biologics Co., Ltd. 94 participants Est. completion 2018-07-17 1 site
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT03259074

    Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar)

    Not yet reported Novartis Pharmaceuticals 859 participants Est. completion 2021-11-29 171 sites
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Active, not recruiting NCT NCT03261102

    TDM Guided Early Optimization of ADAL in Crohn's Disease

    Not yet reported waqqas.afif 200 participants Est. completion 2025-06-01 6 sites
    Other conditions: Crohn Disease, Drug Monitoring, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03266471

    Cytokines and Genes in Therapeutic Response in Crohn's Disease

    Vanderbilt University Medical Center 96 participants Est. completion 2022-05-03 2 sites
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03311464

    A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan

    Not yet reported AbbVie 22 participants Est. completion 2020-04-21 20 sites Stand-alone
    Other conditions: Pyoderma Gangrenosum
    View official trial listing →
  • Completed NCT NCT03316781

    Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis

    Not yet reported Shanghai Henlius Biotech 262 participants Est. completion 2019-04-22 1 site
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT03339089

    Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

    AbbVie 224 participants Est. completion 2021-07-08 10 sites
    Other conditions: Ankylosing Spondylitis (AS), Psoriasis, Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT03357939

    Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects

    Not yet reported Shanghai Henlius Biotech 220 participants Est. completion 2018-09-15 1 site
    Other conditions: Immune System Disorder
    View official trial listing →
  • Completed NCT NCT03389984

    Psoriatic Inflammation Markers Predictive of Response to Adalimumab

    Not yet reported Poitiers University Hospital 85 participants Est. completion 2020-06-18 1 site Stand-alone
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Completed NCT NCT03412747

    A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported UCB Biopharma SRL 478 participants Est. completion 2020-02-26 77 sites
    Other conditions: Chronic Plaque Psoriasis, Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT03445845

    Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 300 participants Est. completion 2024-10-01 35 sites
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT03464136

    Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

    Not yet reported Janssen Scientific Affairs, LLC 386 participants Est. completion 2021-05-21 182 sites Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT03580876

    Addition of Azathioprine in IBD Patients With Immunogenic Failure

    Not yet reported Védrines, Philippe, M.D. 90 participants Est. completion 2020-06-10 1 site
    Other conditions: Clinical Failure After Switch
    View official trial listing →
  • Completed NCT NCT03607903

    Adalimumab Microneedles in Healthy Volunteers

    Not yet reported, Not yet reported Centre for Human Drug Research, Netherlands 24 participants Est. completion 2018-10-30 1 site Stand-alone
    Other conditions: Pain, Injection Site
    View official trial listing →
  • Terminated NCT NCT03619876

    Effects of Abatacept on Myocarditis in Rheumatoid Arthritis

    Not yet reported Columbia University 11 participants Est. completion 2021-09-15 1 site
    Other conditions: Rheumatoid Arthritis, Myocardial Inflammation
    View official trial listing →
  • Status unknown NCT NCT03640637

    The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases

    Odense University Hospital 75 participants Est. completion 2021-08 1 site
    Other conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03651518

    Personalized Therapies in Inflammatory Complex Disease

    Not yet reported Assistance Publique - Hôpitaux de Paris 32 participants Est. completion 2025-11-20 1 site
    Other conditions: Inflammatory Disease, Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT03703817

    Rheumatoid Arthritis Satisfaction Outcome Research

    Pfizer 421 participants Est. completion 2020-03-12 23 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT03737708

    A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

    Not yet reported Astellas Pharma Korea, Inc. 21 participants Est. completion 2020-06-16 10 sites Stand-alone
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT03789292

    A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

    Not yet reported Celltrion 648 participants Est. completion 2020-04-24 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT03808506

    Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Est. completion 2022-07-19 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03816397

    Adalimumab in JIA-associated Uveitis Stopping Trial

    Not yet reported Nisha Acharya 87 participants Est. completion 2025-04-03 21 sites
    Other conditions: Uveitis, JIA
    View official trial listing →
  • Completed NCT NCT03828019

    Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

    Not yet reported JHSPH Center for Clinical Trials 227 participants Est. completion 2024-09-09 26 sites
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT03849404

    Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque Psoriasis

    Not yet reported Alvotech Swiss AG 413 participants Est. completion 2020-07-20 20 sites Stand-alone
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT03885713

    Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

    Not yet reported Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 180 participants Est. completion 2024-12-31 21 sites
    Other conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT03886233

    Treatment Outcome of Uveitis in Autoimmune Diseases

    Assiut University 1 participants Est. completion 2021-02
    Other conditions: Autoimmune Uveitis
    View official trial listing →
  • Completed NCT NCT03890445

    Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease

    Sandoz 63 participants Est. completion 2020-05-08 18 sites
    Other conditions: Crohn´s Disease
    View official trial listing →
  • Completed NCT NCT03895203

    A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

    Not yet reported UCB Biopharma SRL 852 participants Est. completion 2022-07-11 136 sites Stand-alone
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT03906136

    AScalate: Treat-to-target in Axial Spondyloarthritis

    Not yet reported Novartis Pharmaceuticals 304 participants Est. completion 2022-09-22 47 sites Stand-alone
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT03917303

    Control Crohn Safe Trial

    Not yet reported Maastricht University Medical Center 158 participants Est. completion 2026-09 6 sites
    Other conditions: Crohn Disease, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT03917628

    Pharmacokinetics and Safety in Healthy Volunteers

    Not yet reported Sinocelltech Ltd. 146 participants Est. completion 2019-11-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03925441

    Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

    AbbVie 2 participants Est. completion 2019-08-06 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT03927352

    The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

    Not yet reported Sinocelltech Ltd. 330 participants Est. completion 2022-12-31 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT03955861

    Ultrasound Enthesitis Response in Psoriatic Arthritis

    Belfast Health and Social Care Trust 80 participants Est. completion 2021-07-17 1 site
    Other conditions: Psoriatic Arthritis, Psoriasis, Enthesitis
    View official trial listing →
  • Completed NCT NCT03983876

    PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

    Not yet reported Alvotech Swiss AG 207 participants Est. completion 2019-12-03 2 sites Stand-alone
    Other conditions: Phase 1
    View official trial listing →
  • Status unknown NCT NCT04003922

    Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term

    Assistance Publique Hopitaux De Marseille 40 participants Est. completion 2025-10 16 sites
    Other conditions: Rasmussen Encephalitis
    View official trial listing →
  • Completed NCT NCT04009668

    Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

    Not yet reported University of Michigan 7 participants Est. completion 2023-10-03 4 sites Stand-alone
    Other conditions: FSGS, MCD, Focal Segmental Glomerulosclerosis, Minimal Change Disease
    View official trial listing →
  • Completed NCT NCT04018599

    Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

    Not yet reported Fresenius Kabi SwissBioSim GmbH 216 participants Est. completion 2020-03-17 2 sites
    Other conditions: Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn Disease, Ulcerative Colitis, Plaque Psoriasis, Pediatric Plaque Psoriasis, Pediatric Crohns Disease, Hidradenitis Suppurativa, Non-infectious Uveitis
    View official trial listing →
  • Terminated NCT NCT04028713

    Dose Tapering Study of Adalimumab in Psoriasis

    Not yet reported University Hospital, Ghent 19 participants Est. completion 2022-03-22 7 sites Stand-alone
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Completed NCT NCT04045782

    Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders

    Not yet reported Pieter Dewint, MD PhD 130 participants Est. completion 2021-01-29 2 sites
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT04086745

    A Study of Baricitinib in Participants With Rheumatoid Arthritis

    Not yet reported Eli Lilly and Company 1050 participants Est. completion 2025-05-19 119 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT04088409

    A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2028-07 20 sites
    Other conditions: Uveitis
    View official trial listing →
  • Terminated NCT NCT04115748

    Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

    Not yet reported Gilead Sciences 67 participants Est. completion 2021-05-11 74 sites Stand-alone
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Terminated NCT NCT04131322

    Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 24 participants Est. completion 2020-06-08 1 site Stand-alone
    Other conditions: Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT04154852

    ADalimumab in Persistent Early Oligoarthrits Study (ADEOS)

    Not yet reported University of Leeds 22 participants Est. completion 2017-01-16 1 site Stand-alone
    Other conditions: Oligoarthritis
    View official trial listing →
  • Status unknown NCT NCT04194827

    Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring

    Not yet reported Reade Rheumatology Research Institute 267 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT04200547

    Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence

    Not yet reported University Hospital, Montpellier 42 participants Est. completion 2024-06-29 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT04230213

    A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

    Not yet reported Pfizer 455 participants Est. completion 2021-06-22 72 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT04251741

    Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment

    Not yet reported Reade Rheumatology Research Institute 86 participants Est. completion 2024-05-01 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04255134

    Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)

    Not yet reported St George's, University of London 18 participants Est. completion 2022-10-26 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04259138

    Determination of the Optimal Treatment Target in Ulcerative Colitis

    Not yet reported Alimentiv Inc. 672 participants Est. completion 2026-04-13 58 sites
    Other conditions: Colitis, Ulcerative
    View official trial listing →
  • Status unknown NCT NCT04378621

    Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients

    Not yet reported Vastra Gotaland Region 212 participants Est. completion 2025-09-01 1 site
    Other conditions: Rheumatoid Arthritis, Pain, Fatigue, Cognitive Decline, Depression, Brain Diseases, Hand Rheumatism
    View official trial listing →
  • Status unknown NCT NCT04399382

    A Clinical Study to Evaluate the Efficacy of Biologics in SpA

    The University of Hong Kong-Shenzhen Hospital 40 participants Est. completion 2022-12 1 site
    Other conditions: Spondyloarthritis (SpA)
    View official trial listing →
  • Status unknown NCT NCT04422171

    A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

    University Hospital, Grenoble 400 participants Est. completion 2023-01-31 1 site
    Other conditions: IBD Patients, Originator Treatment, Biosimilar, Switch Back
    View official trial listing →
  • Completed NCT NCT04439929

    Comparative Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of Adalimumab in Healthy Subjects

    Not yet reported Turgut İlaçları A.Ş. 168 participants Est. completion 2020-01-16 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04453137

    Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis

    Not yet reported Alvotech Swiss AG 567 participants Est. completion 2021-11-16 25 sites Stand-alone
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT04514796

    Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male Subjects

    Not yet reported Samsung Bioepis Co., Ltd. 188 participants Est. completion 2021-05-15 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT04527380

    A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

    Not yet reported Eli Lilly and Company 101 participants Est. completion 2029-01 43 sites
    Other conditions: Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis
    View official trial listing →
  • Completed NCT NCT04551352

    A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

    Not yet reported Hoffmann-La Roche 20 participants Est. completion 2022-07-28 14 sites Stand-alone
    Obstructive sleep apnea Other conditions: Cutaneous Melanoma, Uveal Melanoma
    View official trial listing →
  • Status unknown NCT NCT04588818

    Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis

    Not yet reported Sun Yat-sen University 30 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Status unknown NCT NCT04610476

    Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

    Not yet reported University of Erlangen-Nürnberg Medical School 270 participants Est. completion 2025-10-19 1 site Stand-alone
    Other conditions: Psoriatic Arthritis, Withdrawal, Reduction
    View official trial listing →
  • Withdrawn NCT NCT04643483

    A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

    Not yet reported UCB Biopharma SRL Est. completion 2026-04
    Other conditions: Crohn's Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT04646187

    De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

    Not yet reported University Medical Center Groningen 148 participants Est. completion 2026-03 7 sites Stand-alone
    Other conditions: Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
    View official trial listing →
  • Withdrawn NCT NCT04655807

    A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease

    Not yet reported Janssen Research & Development, LLC Est. completion 2023-09-04 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Status unknown NCT NCT04731831

    Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

    Aalborg University Hospital 120 participants Est. completion 2025-12-30 1 site
    Other conditions: Arthritis, Rheumatoid, Arthritis, Psoriatic, Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT04750213

    A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)

    AbbVie 60 participants Est. completion 2024-11-11 46 sites
    Other conditions: Pyoderma Gangrenosum
    View official trial listing →
  • Completed NCT NCT04752748

    Power Doppler in Hand Joints of Early RA Patients

    Federal University of São Paulo 48 participants Est. completion 2016-08
    Other conditions: Early Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04772248

    Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)- Cardiovascular Endpoints

    Brigham and Women's Hospital 105711 participants Est. completion 2021-12-30 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04808739

    Adalimumab Biosimilar in Clinical Practice

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 604 participants Est. completion 2021-02-28 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Active, not recruiting NCT NCT04870203

    Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis

    Not yet reported University Hospital, Bordeaux 160 participants Est. completion 2027-03 36 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT04875299

    Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients

    The First Affiliated Hospital of Soochow University 480 participants Est. completion 2023-05 1 site
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Status unknown NCT NCT04882683

    Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

    Not yet reported Shandong Qilu Stem Cells Engineering Co., Ltd. 50 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT04909801

    A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

    Not yet reported Bristol-Myers Squibb 338 participants Est. completion 2027-09-01 75 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT04988308

    A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa

    Not yet reported Janssen Research & Development, LLC 151 participants Est. completion 2022-11-23 54 sites
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT05073315

    A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

    Not yet reported Amgen 425 participants Est. completion 2022-12-19 88 sites Stand-alone
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT05090124

    Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis REALISE

    Not yet reported NHS Greater Glasgow and Clyde 46 participants Est. completion 2024-11-29 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Not yet recruiting NCT NCT05105347

    Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis

    Not yet reported Peking Union Medical College Hospital 130 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Active, not recruiting NCT NCT05108259

    To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects

    Not yet reported Prestige Biopharma Limited 160 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05119452

    Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis

    Not yet reported Medical University of Vienna 85 participants Est. completion 2024-09
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT05135221

    Combination Therapy With Two Biologicals

    Tampere University Hospital 16 participants Est. completion 2021-10-01 1 site
    Other conditions: IBD
    View official trial listing →
  • Status unknown NCT NCT05151848

    Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis

    Not yet reported Chinese SLE Treatment And Research Group 100 participants Est. completion 2026-01-15 4 sites Stand-alone
    Other conditions: Takayasu Arteritis
    View official trial listing →
  • Status unknown NCT NCT05153200

    Early Changes in Pain, Disease Activity, and Ultrasound Evidence of Inflammatory Synovitis in Patients Receiving JAK-inhibitor vs. TNF-inhibitor Therapy for Active Rheumatoid Arthritis: A Feasibility Study.

    Not yet reported Ottawa Hospital Research Institute 40 participants Est. completion 2023-06
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05164198

    REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)

    Not yet reported Hanyang University Seoul Hospital 448 participants Est. completion 2024-10-31 Stand-alone
    Other conditions: Ankylosing Spondylitis, Axial Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT05172817

    Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients

    Not yet reported, Not yet reported Institute for Developing Science and Health Initiatives, Bangladesh 200 participants Est. completion 2022-10-30 1 site Stand-alone
    Other conditions: Pharmacokinetics, Safety, Efficacy, Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05240859

    Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

    Peking University People's Hospital 1600 participants Est. completion 2024-08-30 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT05313620

    Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

    Not yet reported Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 32 participants Est. completion 2026-06-11 1 site
    Other conditions: Ulcerative Colitis, Thromboembolism
    View official trial listing →
  • Completed NCT NCT05320159

    Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)

    Novartis Pharmaceuticals 17743 participants Est. completion 2021-03-31 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT05322473

    Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

    Not yet reported MoonLake Immunotherapeutics AG 234 participants Est. completion 2023-08-30 57 sites Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Status unknown NCT NCT05379049

    Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.

    University of Sulaimani 80 participants Est. completion 2022-10-01 1 site
    Other conditions: Rheumatoid Arthritis, Inflammatory Arthritis, Ankylosing Spondylitis
    View official trial listing →
  • Withdrawn NCT NCT05379322

    The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients

    Not yet reported Abu Dhabi Stem Cells Center Est. completion 2023-03-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05407350

    Validation of an IUS Activity Index

    International Bowel Ultrasound Group e.V. 110 participants Est. completion 2025-06 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT05411211

    An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)

    AbbVie 20 participants Est. completion 2024-09-08 2 sites
    Other conditions: Polyarticular Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT05414201

    A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

    Not yet reported AbbVie 87 participants Est. completion 2024-06-10 7 sites Stand-alone
    Other conditions: Non-infectious Intermediate Posterior- or Pan-uveitis
    View official trial listing →
  • Status unknown NCT NCT05427942

    Yuflyma® (Adalimumab), Patient Experience After Switching

    Celltrion HealthCare France 300 participants Est. completion 2023-03-01 2 sites
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylarthritis, Axial Spondyloarthritis Without Radiographic Evidence of Ankylosing Spondylitis, Psoriatic Arthritis, Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT05502731

    Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis

    Not yet reported Leiden University Medical Center 40 participants Est. completion 2025-10 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05527444

    The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients

    Not yet reported Qilu Hospital of Shandong University 100 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT05530122

    Prognosis in UC After First Biological

    Tampere University Hospital 192 participants Est. completion 2022-08-26
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT05535738

    Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

    Not yet reported, Not yet reported Wei-Che Ko 45 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Skin Inflammation, Allergic Contact Dermatitis
    View official trial listing →
  • Status unknown NCT NCT05542459

    Multi-omics to Predict Responses to Biologics in IBD

    Sixth Affiliated Hospital, Sun Yat-sen University 1050 participants Est. completion 2024-11-01 1 site
    Other conditions: Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT05590416

    A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

    Tianjin Medical University 15 participants Est. completion 2024-12-30 1 site
    Other conditions: Vogt-Koyanagi-Harada Disease, Adalimumab
    View official trial listing →
  • Status unknown NCT NCT05598684

    SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

    Fresenius Kabi, France 600 participants Est. completion 2025-12-30 96 sites
    Other conditions: Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT05633771

    Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting

    Sandoz 562 participants Est. completion 2026-12 51 sites
    Other conditions: Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT05637515

    Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

    Not yet reported Biocon Biologics Inc. 374 participants Est. completion 2023-09-19 36 sites
    Other conditions: Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT05683054

    A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated

    Not yet reported University Hospital, Ghent 19 participants Est. completion 2022-08-22 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT05683626

    Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital

    Sohag University 40 participants Est. completion 2023-12-30 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Status unknown NCT NCT05696106

    Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID

    Assistance Publique - Hôpitaux de Paris 750000 participants Est. completion 2024-01-15 1 site
    Other conditions: Inflammatory Disease
    View official trial listing →
  • Completed NCT NCT05706038

    Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse

    IRCCS San Raffaele 49 participants Est. completion 2022-10-31 1 site
    Other conditions: Inflammatory Bowel Diseases, Rheumatic Disorder
    View official trial listing →
  • Completed NCT NCT05720221

    Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients

    Helwan University 100 participants Est. completion 2023-01-20 1 site
    Other conditions: IBD
    View official trial listing →
  • Status unknown NCT NCT05759104

    Treatment and Fate in Fistulizing Crohn's Disease in a Pediatric Population

    Central Hospital, Nancy, France 40 participants Est. completion 2023-07-01
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT05814627

    Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

    Not yet reported AbbVie 487 participants Est. completion 2026-07-15 218 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05871086

    Coenzyme Q10 in Juvenile Idiopathic Arthritis Patients

    Not yet reported, Not yet reported Nourhan Elsherif 60 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT05909852

    A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

    Not yet reported Amgen 372 participants Est. completion 2021-11-24 3 sites
    Other conditions: Adalimumab
    View official trial listing →
  • Completed NCT NCT05913817

    The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.

    Jamp Pharma Corporation 324 participants Est. completion 2025-08-25 1 site
    Other conditions: Crohn Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Plaque Psoriasis, Hidradenitis Suppurativa
    View official trial listing →
  • Not yet recruiting NCT NCT05928754

    Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS

    Not yet reported Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2000 participants Est. completion 2028-08 Stand-alone
    Other conditions: Non-infectious Uveitis
    View official trial listing →
  • Completed NCT NCT05957120

    Subclinical Impairment of Cardiovascular System in Patients With Psoriasis

    University Medical Centre Ljubljana 100 participants Est. completion 2022-11-30 1 site
    Other conditions: Psoriasis, Inflammation, Endothelial Dysfunction, Metabolic Disturbance, Insulin Resistance, Coagulation Disorder, Thrombocyte Disorders
    View official trial listing →
  • Status unknown NCT NCT05986903

    Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.

    Hospital del Rio Hortega 280 participants Est. completion 2025-01-01 1 site
    Other conditions: Drug Monitoring, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT05995691

    Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

    Not yet reported Amgen 179 participants Est. completion 2015-12-04
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06016517

    Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis

    Tufts Medical Center 18 participants Est. completion 2028-12-15 1 site
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Status unknown NCT NCT06033469

    Therapeutic Monitoring of Infliximab and Adalimumab

    IRCCS Burlo Garofolo 100 participants Est. completion 2024-06-30 3 sites
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Status unknown NCT NCT06117423

    Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease

    Not yet reported, Not yet reported University Medical Center Groningen 21 participants Est. completion 2025-06 1 site Stand-alone
    Other conditions: Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT06126835

    A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

    Bristol-Myers Squibb 2828 participants Est. completion 2032-06-30 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT06242652

    A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)

    Not yet reported Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 250 participants Est. completion 2025-06-15 1 site
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Not yet recruiting NCT NCT06258915

    Treatment FOr Corticosteroid Dependent UveitiS

    Not yet reported Assistance Publique - Hôpitaux de Paris 120 participants Est. completion 2027-11-01 Stand-alone
    Other conditions: Non Infectious Uveitis
    View official trial listing →
  • Completed NCT NCT06269185

    Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

    Vastra Gotaland Region 271 participants Est. completion 2024-10-18 1 site
    Other conditions: Ulcerative Colitis, Inflammatory Bowel Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT06333210

    Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

    Not yet reported Biocad 421 participants Est. completion 2028-02 32 sites Stand-alone
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Not yet recruiting NCT NCT06339216

    A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

    Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2026-11-30 Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT06370156

    Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients

    Egymedicalpedia 100 participants Est. completion 2025-06-10 1 site
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Not yet recruiting NCT NCT06390436

    Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 320 participants Est. completion 2030-12 11 sites Stand-alone
    Other conditions: Uveitis, Chronic Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06440629

    Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)

    Not yet reported Diakonhjemmet Hospital 387 participants Est. completion 2027-12-31 22 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT06527534

    Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

    Not yet reported Universita di Verona 30 participants Est. completion 2025-09-15 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT06563635

    Frequency of Tuberculosis in Psoriasis Patients

    Bezmialem Vakif University 719 participants Est. completion 2023-07-31 1 site
    Other conditions: Psoriasis Vulgaris, Tuberculosis
    View official trial listing →
  • Completed NCT NCT06600009

    Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database

    Novartis 534 participants Est. completion 2023-09-15 1 site
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT06640517

    Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis

    Not yet reported Biocad 140 participants Est. completion 2028-02 14 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Not yet recruiting NCT NCT06742606

    Efficacy of Biological Therapy in Pediatric Inflammatory Bowel Disease

    Not yet reported Ain Shams University 40 participants Est. completion 2026-12-13 Stand-alone
    Other conditions: Effect of Drug
    View official trial listing →
  • Not yet recruiting NCT NCT06849739

    Study on the Correlation and Consistency of Measuring Biologic Drug Plasma Concentrations Based on Different Detection Methods

    Nanfang Hospital, Southern Medical University 60 participants Est. completion 2025-12-31 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT06926478

    Subconjunctival Humira for Boston Keratoprosthesis

    Not yet reported Massachusetts Eye and Ear Infirmary 8 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Penetrating Keratoplasty, Multiple Graft Failure, Ocular Cicatricial Pemphigoid, Stevens-Johnson Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07013838

    The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis

    Not yet reported Chinese SLE Treatment And Research Group 50 participants Est. completion 2028-03-31 1 site
    Other conditions: Takayasu Arteritis (TAK)
    View official trial listing →
  • Completed NCT NCT07041112

    Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors

    Juan Ruano Ruiz 1000 participants Est. completion 2024-06-01 1 site
    Metabolic syndrome Other conditions: Psoriasis, Psoriatic Arthritis (PsA), Cardiovascular Risk Factors, Drug Survival, Pharmacogenetics
    View official trial listing →
  • Active, not recruiting NCT NCT07093827

    A Prospective Cohort Study on the Effect of Spinal Spinal Cord Injury on Sexual Function in Male Patients

    Peking University Third Hospital 1600 participants Est. completion 2030-12-31 1 site
    Other conditions: Sexual Function Abnormal, Spinal Cord Injuries (SCI)
    View official trial listing →
  • Completed NCT NCT07113834

    Characteristics of Ankylosing Spondylitis Associated Uveitis

    Benha University 22 participants Est. completion 2024-08-01 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Not yet recruiting NCT NCT07137858

    Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 70 participants Est. completion 2027-12-31 Stand-alone
    Other conditions: Oral Squamous Cell Carcinoma (OSCC), Neoadjuvant Chemoimmunotherapy
    View official trial listing →
  • Completed NCT NCT07140666

    Analysis of Influence Factors on Osteopenia in Different Treatment of Psoriasis

    Chongli Yu 100 participants Est. completion 2022-12-28 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT07147257

    A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA® (Adalimumab) 40 mg/0.4 mL in Healthy Chinese Adult Participants Under Fasting Conditions

    Not yet reported Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. 238 participants Est. completion 2025-05-29 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Active, not recruiting NCT NCT07177209

    Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

    Pfizer 4000 participants Est. completion 2026-07-31 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT07181694

    A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects

    Not yet reported Biocad 444 participants Est. completion 2026-02-12 4 sites Stand-alone
    Other conditions: Healthy Adult Male
    View official trial listing →
  • Not yet recruiting NCT NCT07208539

    AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

    Not yet reported Shanghai Zhongshan Hospital 77 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07221890

    A Trial of Academic Detailing to Promote Prescribing of Biosimilars

    Not yet reported Brigham and Women's Hospital 1325 participants Est. completion 2027-03-31 2 sites Stand-alone
    Other conditions: Autoimmune Diseases, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD), Psoriasis (PsO)
    View official trial listing →
  • Not yet recruiting NCT NCT07258641

    Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease

    Not yet reported, Not yet reported University Medical Center Groningen 30 participants Est. completion 2028-04-01 1 site Stand-alone
    Other conditions: Ulcerative Colitis (UC), Crohn Disease (CD)
    View official trial listing →
  • Active, not recruiting NCT NCT07348588

    Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

    Not yet reported, Not yet reported Centro de Pesquisa Rubens Siqueira 30 participants Est. completion 2026-12-01 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Extensive Macular Atrophy With Pseudodrusen (EMAP)
    View official trial listing →
  • Not yet recruiting NCT NCT07388446

    MAIT Cells in Hidradenitis Suppurativa

    Not yet reported Hospices Civils de Lyon 45 participants Est. completion 2027-02-01 1 site Stand-alone
    Other conditions: Hidradenitis Suppurativa (HS)
    View official trial listing →
  • Not yet recruiting NCT NCT07398651

    Apremilast and Adalimumab in Psoriatic Arthritis Patients

    Not yet reported Tanta University 60 participants Est. completion 2026-12-30 1 site Stand-alone
    Other conditions: Psoriatic Arthritis, Ultrasound Assessment, TNF
    View official trial listing →
  • Not yet recruiting NCT NCT07704645

    The Clinical Study of Adalimumab Combined With Other Anti-tumor Therapy as a Treatment for Resectable Non-small Cell Lung Cancer

    Not yet reported Suzhou Suncadia Biopharmaceuticals Co., Ltd. 180 participants Est. completion 2029-12 1 site
    Other conditions: Resectable Non-small Cell Lung Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07773623

    An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis

    Not yet reported Tianjin Medical University 30 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Uveitis
    View official trial listing →
  • Not yet recruiting NCT NCT07788807

    A Study to Investigate How Well an Intracolonic Formulation of Two Monoclonal Antibodies is Tolerated in Healthy Participants and the Ability for the Antibodies to be Taken up by the Body Via the Colon

    Not yet reported Surmount Services, Inc. 18 participants Est. completion 2026-12-30 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Not yet recruiting NCT NCT07836283

    Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Treatment of Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis Refractory to NSAIDs With Hypothesis of Superiority of Bimekizumab

    Not yet reported University Hospital, Rouen 150 participants Est. completion 2030-10-15 1 site
    Other conditions: Axial or Predominantly Axial SpondyloArthritis With or Without Psoriasis
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Adalimumab, Adalimumab-aacf, Adalimumab-ryvk, Adalimumab-adbm

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.